跳至主要内容
临床试验/NCT07704359
NCT07704359尚未招募4 期

Randomized Antibiotics for Prevention of Fistula After Incision and Drainage of First-Episode Perianal Abscess (RAPID): A Randomized Controlled Trial

University of Illinois at Chicago1 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2026年8月3日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
236
试验地点
1
主要终点
Number of participants who develop fistula in ano within 6 months after incision and drainage

研究概览

简要总结

The goal of this clinical trial is to learn if antibiotics can prevent the formation of fistula-in-ano after incision and drainage of a first time of perianal abscess in adults. A perianal abscess is a collection of infected fluid near the anus. A Fistula-in-ano is an abnormal tunnel that can form between the anal canal and the skin after an abscess.

The main questions it aims to answer are:

Does taking antibiotics after incision and drainage of a perianal abscess lower the chance of developing a Fistula-in-ano? What medical problems or side effects do participants have after taking antibiotics or not taking antibiotics?

Researchers will compare participants who recieve antibiotics after abscess drainage with paticipants who do not recieve antibiotics after abscess drainage, to see if antibiotics lower the chance of developing a Fistula-in-ano.

Participants will:

Be randomly assigned to recieve antibiotics for 7 days after abscess incision and drainage or to not recieve antibiotics after abscess incision and drainage.

Attend follow-up clinic visits after incision and drainage as part of their standard of care.

Complete follow-up phone call about 12 months after incision and drainage. Allow the study team to review their medical record for abscess treatment, symptoms, recurrence, fistula-in-ano formation, additional procedures, and antibiotics side effects.

详细描述

This is a single-center, randomized, open-label clinical trial evaluating whether a 7-day course of postoperative antibiotics after standard of care incision and drainage of a first-time perianal abscess reduces subsequent anal fistula formation compared with no postoperative antibiotics.

Perianal abscess is a common anorectal condition treated primarily with incision and drainage. After drainage, some patients later develop an anal fistula, which is an abnormal tract between the anal canal and the perianal skin. The role of routine antibiotics after adequate drainage remains uncertain, especially in patients without high-risk clinical features that would otherwise require antibiotics as part of standard care. This study is designed to evaluate whether a short postoperative antibiotic course can reduce fistula formation after a first episode of perianal abscess.

Eligible adult participants with a first-time perianal abscess requiring incision and drainage will be randomized in a 1:1 ratio to either postoperative antibiotics or no postoperative antibiotics. Participants assigned to the antibiotic arm will receive amoxicillin/clavulanate for 7 days. Participants with penicillin allergy may receive ciprofloxacin plus metronidazole instead. Participants assigned to the no-antibiotic arm will not receive postoperative antibiotics unless antibiotics are later determined to be medically necessary by the treating clinician.

All participants will receive standard clinical care for the perianal abscess, including incision and drainage as determined by the treating surgical team. The study does not change the technical approach to drainage or other clinically indicated care. The research intervention is the randomized postoperative antibiotic strategy.

Participants will be followed through routine clinical visits and a 12-month follow-up phone call. The study will collect information from the medical record and follow-up contacts regarding fistula formation, recurrent abscess, additional procedures or treatment, emergency department visits or readmissions, antibiotic use, medication adherence, and antibiotic-related adverse events. The findings may help clarify whether routine postoperative antibiotics should be used after drainage of first-time perianal abscess in patients without other clinical indications for antibiotics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

盲法说明

Open-label trial. Participants and treating clinicians will know the assigned postoperative management strategy. Outcomes will be assessed through clinical follow-up and medical record review.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • First episode of perianal abscess requiring incision and drainage
  • Able to provide informed consent
  • English or Spanish speaking patient
  • Treating surgical team has determined that incision and drainage is clinically indicated as part of standard care

排除标准

  • Known fistula-in-ano at presentation
  • Prior perianal abscess within 12 months
  • History of inflammatory bowel disease, including Crohn's disease or ulcerative colitis
  • Known or suspected anorectal malignancy
  • Necrotizing soft tissue infection or Fournier's gangrene
  • Systemic infection or sepsis
  • Significant surrounding cellulitis or extensive soft-tissue infection for which antibiotics are clinically indicated
  • Immunocompromised or immunosuppressed status, including active chemotherapy or radiation therapy, history of transplant, chronic systemic steroids, biologic immunosuppressive therapy, advanced or uncontrolled HIV/AIDS, or other clinically significant immunosuppression
  • Cardiac condition requiring antibiotic prophylaxis or antibiotic therapy for procedures involving infected tissue
  • Need for non-study antibiotics at the time of enrollment for another infection or medical indication
  • Contraindication, allergy, or intolerance to all study antibiotic regimens
  • Adult unable to provide informed consent

结局指标

主要结局

Number of participants who develop fistula in ano within 6 months after incision and drainage

时间窗: 6 months after incision and drainage

Anal fistula formation will be assessed as a binary outcome for each participant. Fistula will be defined as documentation of a clinically diagnosed anal fistula during follow-up, based on clinical examination, imaging, operative or procedure findings, or medical record documentation.

次要结局

  • Number of participants who develop Fistula in Ano within 12 months after incision and drainage(12 months after incision and drainage)
  • Number of participants who develop recurrent perianal abscess within 12 months after incision and drainage.(12 months after incision and drainage)
  • Number of participants who require an additional abscess or fistula related procedure or intervention within 12 months after incision and drainage.(12 months after incision and drainage)
  • Number of participants with an abscess or fistula emergency department visit or hospital readmission within 12 months after incision and drainage.(12 months after incision and drainage)
  • Number of participants with antibiotic adverse events by event type within 30 days after incision and drainage.(Within 30 days after incision and drainage)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamad Abdulhai

Assistant Professor of Surgery

University of Illinois at Chicago

研究点 (1)

Loading locations...

相似试验